ClinConnect ClinConnect Logo
Search / Trial NCT03129711

Patient Satisfaction of Glazed IPS Empress CAD Versus Glazed Celtra Duo Ceramic Laminate Veneers

Launched by CAIRO UNIVERSITY · Apr 24, 2017

Trial Information

Current as of May 07, 2025

Unknown status

Keywords

ClinConnect Summary

IPS Empress CAD is a leucite glass-ceramic of the SiO2-Al2-O3-K2O material systems with leucite crystal ranging from 5 to 10 µm in size. The leucite crystals increase the material strength and interferes with crack propagation, while the fracture energy is absorbed by the crystalline phase. The resistance and flexural strength (160 Mpa) is improved by the difference in the coefficient of thermal expansion between the glass phase and the crystalline phase and the cooling process following sintering phase.

CELTRA DUO: is a new generation of glass ceramic material. With the aid of a new manuf...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All subjects are required to be
  • 1. From 18-50 years old, be able to read and sign the informed consent document.
  • 2. Physically and psychologically able to tolerate conventional restorative procedures
  • 3. have no active periodontal or pulpal diseases, have teeth with good restorations
  • 4. Patients with teeth problems indicated for laminate veneer:
  • 1. Discoloration
  • 2. Fracture not involving more than 50% enamel loss
  • 3. Mild malposition
  • 4. Diastema
  • 5. Enamel fluorosis
  • 6. Stained or defective restorations
  • 5. Willing to return for follow-up examinations and evaluation
  • Exclusion Criteria:
  • 1. Patients in the growth stage with partially erupted teeth 2. Patient with fractured teeth of more than 50% enamel loss 3. Patients with poor oral hygiene and motivation 4. Pregnant women's 5. Patient with post and core endodontically treated teeth 6. Psychiatric problems or unrealistic expectations 7. Lack of opposite occluding dentition in the area intended for restoration 8. Patients involved in contact sports 9. Teeth with deep discoloration

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials